Patent details

Basic Information

Publication number:

EP1483294

PCT Application Number:

GB2003000890

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037434214

PCT Publication Number:

WO2003074567

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INTERNALIZING ANTI-CD74 ANTIBODIES AND METHODS OF USE

French Title of Invention:

INTERNALISATION D'ANTICORPS ANTI-CD74 ET METHODES D'UTILISATION CORRESPONDANTES

German Title of Invention:

INTERNALISIERUNG VON ANTI CD74 MONOKLONALEN ANTIKÖRPERN UND DEREN VERWENDUNGEN

SPC Number:

Dates

Filing date:

03/03/2003

Grant date:

11/08/2010

EP Publication Date:

08/12/2004

PCT Publication Date:

12/09/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2004

EP B1 Publication Date:

11/08/2010

EP B2 Publication Date:

30/10/2019

EP B3 Publication Date:

Lapsed date:

03/03/2011

Expiration date:

03/03/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/10/2019

 

 

Name:

Immunomedics, Inc.

Address:

300 American Road, Morris Plains, NJ 07950, United States (US)

Inventor

1

Name:

QU, Zhengxing

Address:

United States (US)

2

Name:

GOLDENBERG, David, M.

Address:

United States (US)

3

Name:

LEUNG, Shui-on, 10c, University Residence

Address:

China (CN)

4

Name:

HANSEN, Hans

Address:

United States (US)

Priority

Priority Number:

360259 P

Priority Date:

01/03/2002

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 35/02; C07K 16/28; G01N 33/574;

Publication

European Patent Bulletin

Issue number:

201944

Publication date:

30/10/2019

Description:

Patent maintained (B2 publication)

Filing date	Document type	Number of pages